» Articles » PMID: 18606650

Increased Frequency of EBV-specific Effector Memory CD8+ T Cells Correlates with Higher Viral Load in Rheumatoid Arthritis

Overview
Journal J Immunol
Date 2008 Jul 9
PMID 18606650
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

EBV is a candidate trigger of rheumatoid arthritis (RA). We determined both EBV-specific T cell and B cell responses and cell-associated EBV DNA copies in patients with RA and demographically matched healthy virus carriers. Patients with RA showed increased and broadened IgG responses to lytic and latent EBV-encoded Ags and 7-fold higher levels of EBV copy numbers in circulating blood cells. Additionally, patients with RA exhibited substantial expansions of CD8(+) T cells specific for pooled EBV Ags expressed during both B cell transformation and productive viral replication and the frequency of CD8(+) T cells specific for these Ags correlated with cellular EBV copy numbers. In contrast, CD4(+) T cell responses to EBV and T cell responses to human CMV Ags were unchanged, altogether arguing against a defective control of latent EBV infection in RA. Our data show that the regulation of EBV infection is perturbed in RA and suggest that increased EBV-specific effector T cell and Ab responses are driven by an elevated EBV load in RA.

Citing Articles

Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.

Thomas O, Haigh T, Croom-Carter D, Leese A, Wijck Y, Douglas M PLoS Pathog. 2024; 20(6):e1012177.

PMID: 38843296 PMC: 11156336. DOI: 10.1371/journal.ppat.1012177.


Antibody Cross-Reactivity in Auto-Immune Diseases.

Trier N, Houen G Int J Mol Sci. 2023; 24(17).

PMID: 37686415 PMC: 10487534. DOI: 10.3390/ijms241713609.


Immune dysregulation and pathogenic pathways mediated by common infections in rheumatoid arthritis.

Salehi S, Dezfouli S, Azadeh H, Khosravi S Folia Microbiol (Praha). 2023; 68(3):325-335.

PMID: 36680729 DOI: 10.1007/s12223-023-01036-0.


Clinicopathological findings, prognosis, and Epstein-Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders.

Kimura S, Oshiro Y, Iwasaki H, Kadowaki M, Ogata M, Daa T BMC Cancer. 2022; 22(1):1342.

PMID: 36544095 PMC: 9773610. DOI: 10.1186/s12885-022-10358-0.


Altered Immune Response to the Epstein-Barr Virus as a Prerequisite for Multiple Sclerosis.

Laderach F, Munz C Cells. 2022; 11(17).

PMID: 36078165 PMC: 9454695. DOI: 10.3390/cells11172757.


References
1.
Toussirot E, Wendling D, Tiberghien P, Luka J, Roudier J . Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis. Ann Rheum Dis. 2000; 59(7):533-8. PMC: 1753187. DOI: 10.1136/ard.59.7.533. View

2.
Grogan J, Kramer A, Nogai A, Dong L, Ohde M, Schneider-Mergener J . Cross-reactivity of myelin basic protein-specific T cells with multiple microbial peptides: experimental autoimmune encephalomyelitis induction in TCR transgenic mice. J Immunol. 1999; 163(7):3764-70. View

3.
Amyes E, Hatton C, Montamat-Sicotte D, Gudgeon N, Rickinson A, McMichael A . Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection. J Exp Med. 2003; 198(6):903-11. PMC: 2194204. DOI: 10.1084/jem.20022058. View

4.
Voo K, Fu T, Wang H, Tellam J, Heslop H, Brenner M . Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes. J Exp Med. 2004; 199(4):459-70. PMC: 2211826. DOI: 10.1084/jem.20031219. View

5.
Teng Y, Levarht E, Hashemi M, Bajema I, Toes R, Huizinga T . Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment. Arthritis Rheum. 2007; 56(12):3909-18. DOI: 10.1002/art.22967. View